Overview

Intravenous Treatment of Anemia in Pregnancy

Status:
Completed
Trial end date:
2006-07-31
Target enrollment:
0
Participant gender:
Female
Summary
The investigators assess and compare the efficacy of anemia treatment in pregnant women with anemia of chronic disease with true iron deficiency and in women with iron deficiency anemia.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Zurich
Treatments:
Epoetin Alfa
Ferric Compounds
Ferric Oxide, Saccharated
Iron
Criteria
Inclusion Criteria:

- pregnant women with hemoglobin between 8.0 and 9.9 g/dl and serum ferritin <15 μg/l

Exclusion Criteria:

- vitamin B12 deficiency anemia

- folic acid deficiency anemia

- hemoglobinopathy

- multiples

- liver disease

- kidney disease